COVID-19

Two fools debating lol. Both Quest and BIO have AT LEAST 4 day TATs.... Patient could pass away in that time.

So much for your 4 day hypothesis.

Mayor De Blasio, NYC Health + Hospitals And Bioreference Laboratories Announce Expanded Capacity To Allow 5,000 Daily COVID-19 Tests

NEW YORK – Mayor de Blasio announced today that beginning Thursday, March 19th, NYC Health + Hospitals will expand their COVID-19 testing capacity by 5,000 tests per day through a partnership with OPKO Health's BioReference Laboratories. Under the agreement reached last night, NYC Health + Hospitals will begin sending tests to BioReference by Thursday. Results will be produced within 1-2 days, halving the current pace of turnaround from private reference labs.

"This expanded testing for H+H is critical to protecting the New Yorkers most at risk in this epidemic, especially people with chronic health conditions," said Mayor Bill de Blasio. "The new partnership between H+H and BioReference will get us the increased testing and faster results helping save lives."

"In support of the public health system as they provide healthcare to vulnerable and at-risk populations, BioReference is committed to prioritizing hospital patients suspected of COVID-19 infections and aid front-line physicians and healthcare providers to quickly and efficiently diagnose patients," said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories. "In addition to the drive-through facilities, this collaboration is yet another example of how the private sector can assist with government agencies to help combat this epidemic."





 






So much for your 4 day hypothesis.

Mayor De Blasio, NYC Health + Hospitals And Bioreference Laboratories Announce Expanded Capacity To Allow 5,000 Daily COVID-19 Tests

NEW YORK – Mayor de Blasio announced today that beginning Thursday, March 19th, NYC Health + Hospitals will expand their COVID-19 testing capacity by 5,000 tests per day through a partnership with OPKO Health's BioReference Laboratories. Under the agreement reached last night, NYC Health + Hospitals will begin sending tests to BioReference by Thursday. Results will be produced within 1-2 days, halving the current pace of turnaround from private reference labs.

"This expanded testing for H+H is critical to protecting the New Yorkers most at risk in this epidemic, especially people with chronic health conditions," said Mayor Bill de Blasio. "The new partnership between H+H and BioReference will get us the increased testing and faster results helping save lives."

"In support of the public health system as they provide healthcare to vulnerable and at-risk populations, BioReference is committed to prioritizing hospital patients suspected of COVID-19 infections and aid front-line physicians and healthcare providers to quickly and efficiently diagnose patients," said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories. "In addition to the drive-through facilities, this collaboration is yet another example of how the private sector can assist with government agencies to help combat this epidemic."





Fake News
 












So much for your 4 day hypothesis.

Mayor De Blasio, NYC Health + Hospitals And Bioreference Laboratories Announce Expanded Capacity To Allow 5,000 Daily COVID-19 Tests

NEW YORK – Mayor de Blasio announced today that beginning Thursday, March 19th, NYC Health + Hospitals will expand their COVID-19 testing capacity by 5,000 tests per day through a partnership with OPKO Health's BioReference Laboratories. Under the agreement reached last night, NYC Health + Hospitals will begin sending tests to BioReference by Thursday. Results will be produced within 1-2 days, halving the current pace of turnaround from private reference labs.

"This expanded testing for H+H is critical to protecting the New Yorkers most at risk in this epidemic, especially people with chronic health conditions," said Mayor Bill de Blasio. "The new partnership between H+H and BioReference will get us the increased testing and faster results helping save lives."

"In support of the public health system as they provide healthcare to vulnerable and at-risk populations, BioReference is committed to prioritizing hospital patients suspected of COVID-19 infections and aid front-line physicians and healthcare providers to quickly and efficiently diagnose patients," said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories. "In addition to the drive-through facilities, this collaboration is yet another example of how the private sector can assist with government agencies to help combat this epidemic."




It’s really sad how BIO isn’t telling everyone they’re going to pull out 1-2 results without the ability to do so (no reagents)....

Guess it’s why YOUR SITE says 3 days, which really means it’s going to be longer TAT with reflex. It’s the BIO way of conning people.

M062 : COMPREHENSIVE RESPIRATORY PANEL WITH RFLX TO COVID-19
INFORMATION
Alternate Name:

Comprehensive Respiratory Panel with Rflx to COVID-19
Clinical Utility:
Assess for various viral and bacterial infectious agents associated with symptomatic upper respiratory infections.
Methodology:

Polymerase Chain Reaction

ORDERING
Test Code:

M062-8
Turnaround Time:

3 days
Preferred Specimen:

Swab-Star Swab
Alternative Specimen:

Swab-Viral Culturette
Specimen Comment:
Primary container: Viral Swab-Media Male and Flu Naso (item #510)
NOTE: The Comprehensive Respiratory Panel does not include testing for the detection of the 2019 Novel Coronavirus (2019-nCoV) first identified in Wuhan, China. It does test for several other Coronaviridae (229E, HKU1, NL63 and OC43).
TAT will increase if reflexes to COVID-19